基金项目 ： 国家自然科学基金资助项目（No ． ３０６００８１４） ；上海市科学技术委员会基金资助项目（No ． ０５Z R１４１４４） Co rrespondence ： C hangquan LIN G ， MD ， P rofessor ； T el ： ０２１２５０７０８８１ ； Email ： Lingc hangquan ＠ hot mail ． co m
Objective ： To investigate the antitumor effect of bufalin and its regulation on Bcl２ and Bax proteins in orthotopically transplanted tumor of human hepatocellular carcinoma in nude mice ． Methods ：Orthotopically transplanted tumor of human hepatocellular carcinoma was established in nude mice ． The mice were randomly divided into five groups ： highdose bufalintreated group （１ ．５ mg／kg） ， medium dose bufalintreated group （１ mg／kg） ， lowdose bufalintreated group （ ０ ．５ mg／kg） ， adriamycintreated group （ ８ ．０ mg／kg） ， and normal salinetreated group ． After ２５ days ， mice were sacrificed ． The tumor volume was measured ， and the pathological changes of tumor tissues were detected by HE staining to observe the tumor necrosis degree ． Cell morphological changes were also observed by an electron microscopy ． Label index of tumor cell apoptosis was assessed by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling （ TUNEL） ， and the expressions of Bcl２ and Bax proteins were determined by immunohistochemical method ． Results ： The tumor volume in the bufalintreated groups was shrunk significantly compared with that in the normal salinetreated group （ P ＜ ０ ．０１ ） ． The survival time of the bufalintreated groups was prolonged compared with that of the adriamycintreated group and the normal salinetreated group（ P ＜ ０ ．０５） ． Apoptotic characteristics could be seen in tumor tissues of the bufalintreated groups ．The label index of tumor cell apoptosis in the bufalintreated groups （５ ．８７ ± ２ ．１３ ， ８ ．８６ ± ２ ．９６ and １０ ．６０ ± ３ ．４２ in low ， medium and highdose groups respectively） was higher than that in the adriamycintreated group （３ ．２８ ± ０ ．９８） （ P ＜ ０ ．０５ ， P ＜ ０ ．０１） ． The expression of Bax was upregulated ， while no changes were detected as to Bcl２ protein in tumors of the bufalintreated groups ． Conclusion ： Bufalin has significant antitumor effect on the orthotopically transplanted tumor of human
hepatocellular carcinoma in nude mice ． Its effect might be related to upregulation of Bax protein and inducement of the tumor cell apoptosis ． Keywords ：bufalin ； liver neoplasms ； apoptosis ； Bcl２ ； Bax ； nude mice Gu W ， Han KQ ， Su YH ， Huang XQ ， Ling C Q ． J Chin Integr Med ／ Zhong Xi Yi Jie H e X ue Bao ，２００７ ； ５ （２） ： １５５１５９ ． Received November ６ ，２００６ ； published online March １５ ， ２００７ ． Free full text （PDF） is available at w w w ．jcimjournal ．com Table 1 Changes of mouse body weight and tumor volume of human hepatocellular orthotopically transplanted tumor induced by bufalin
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